Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy. AACPDM Treatment Outcomes Committee Review Panel.
Butler
C
C
argonauta@foxinternet.net
Campbell
S
S
D001418:Baclofen / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D002547:Cerebral Palsy / Q000188:drug therapy* / Q000473:pathology; D002648:Child; D002986:Clinical Trials as Topic; D006801:Humans; D007278:Injections, Spinal; D007866:Leg; D009125:Muscle Relaxants, Central / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D009128:Muscle Spasticity / Q000188:drug therapy*; D016896:Treatment Outcome
D009125:Muscle Relaxants, Central; D001418:Baclofen